Characteristics of Abdominal Fluid in Patients With Diverticulitis Hinchey III or IV
Study of Changes in Abdominal Fluid in Connection With Peritonitis. A Descriptive Study in Patients With Purulent or Fecal Peritonitis.
1 other identifier
observational
50
1 country
1
Brief Summary
Perforated diverticulitis of the colon can be complicated by peritonitis, either purulent or fecal. Both are life threatening conditions requiring emergency surgery. The background in terms of reasons for inflammation (diverticulitis) and perforation to develop is unknown. In this study we focus on specific changes associated with inflammation, both in tissues and of fecal and mucosal microbiota.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 5, 2020
CompletedFirst Posted
Study publicly available on registry
June 11, 2020
CompletedStudy Start
First participant enrolled
September 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
April 27, 2026
April 1, 2026
4.7 years
June 5, 2020
April 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
inflammatory response
determination of levels of 92 proteins in abdominal fluid and blood
index surgery (Groups I and II)/ emergency room (Group III)
Secondary Outcomes (2)
inflammatory response in tissue
index surgery (Groups I and II)/ emergency room (Group III)
microbiota composition
index surgery (Groups I and II)/ emergency room (Group III)
Study Arms (3)
Group I
Patients undergoing emergency surgery due to perforated diverticulitis with peritonitis. No intervention, samples from abdominal fluid, blood, tissue, feces
Group II
Patients with colorectal cancer undergoing elective surgery. No intervention. Samples as for Group I
Group III
Patients with mild diverticulitis, not undergoing surgery. No intervention. Samples from blood and feces.
Eligibility Criteria
The aim is to study immune responses in patients with perforated divrticulitis leading to peritonitis and emergency surgery. This group will be compared with patients operated for colorectal cancer and patients with uncomplicated (mild) diverticulitis not undergoing surgery.
You may qualify if:
- Signs of perforated diverticulitis with peritonitis and decision to perform emergency surgery (Group I)
- Signs of acute diverticulitis and no decision of emergency surgery (Group II)
- Patients with colorectal cancer planned for elective surgery (Group III)
You may not qualify if:
- No surgery performed (Group I and III)
- Withdrawn consent (any group)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sahlgrenska University Hospitallead
- Göteborg Universitycollaborator
Study Sites (1)
Sahlgrenska University Hospital/Östra
Gothenburg, Västra Götaland County, SE 416 85, Sweden
Biospecimen
periferal blood, abdominal fluid, colon wall, feces
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eva Haglind, MD,PhD
Sahlgrenska univesitetssjukhuset
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
June 5, 2020
First Posted
June 11, 2020
Study Start
September 21, 2021
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
December 1, 2027
Last Updated
April 27, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share